WFI
UTHR icon

West Family Investments’s United Therapeutics UTHR Stock Holding History

West Family Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
530
+67
+14% +$37.7K 0.08% 349
2026
Q1 		$275K Sell
463
-23
-5% -$11.5K 0.1% 193
2025
Q4 		$237K Hold
486
– – 0.06% 307
2025
Q3 		$204K Buy
+486
New +$163K 0.05% 354

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

West Family Investments's UTHR Position: Q2 2026 in Review

West Family Investments increased its United Therapeutics (UTHR) stake by 14% in Q2 2026, buying an estimated $37.7K and bringing the position to 530 shares worth $287K. The position accounts for 0.08% of the portfolio, ranked #349.

West Family Investments first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • West Family Investments held 530 shares of United Therapeutics worth $287K as of Q2 2026.
  • West Family Investments bought 67 United Therapeutics shares in Q2 2026, an estimated $37.7K.
  • United Therapeutics made up 0.08% of West Family Investments's portfolio in Q2 2026, its #349 holding.
  • West Family Investments first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.